By Deborah Ruff, Head of US & International Arbitration, Julia Kalinina Belcher, Counsel, and Charles H Golsong, Counsel, Pillsbury Winthrop Shaw Pittman LLP – On 22 May 2020, the Tribunal de Commerce of Paris ordered the insurance giant AXA France IARD SA to pay Maison Rostang, a Michelin-starred Parisian restaurant,
AlbionVC managed UCL Technology Fund, in collaboration with UCL Business, has held the first close of Fund 2, with a GBP100 million target.
KKR has agreed to acquire a majority stake in MasterD, a vocational training company in Spain. Luis Gomez, MasterDs’s founder, and management team will reinvest alongside KKR. The investment in MasterD is the second in Europe by the KKR Global Impact fund, following its investment in UK recycling and responsible
Jan Pensaert is the founder and managing partner of Valiance, a global life sciences investor focused on addressing the unmet needs of a growing and ageing population. Valiance makes an impact through investments in medtech, with an additional focus on digital and nutritional health.
BGF’s total H1 investment stands at GBP177 million, including GBP128 million into new portfolio companies and GBP49 million into existing portfolio companies. BGF backed 24 new companies in the first half of 2020, while completing eight exits. Some of its latest deals include British ceramics manufacturing company Emma Bridgewater, Bayfield
PROfounders Capital and Calm/Storm Ventures have invested GBP1 million into sex therapy app Blueheart. The fresh capital will be used to expand the available suite of therapy sessions and advance therapeutic research, as well as improving the app’s AI capabilities. The app provides sex and relationship therapy based on
The Untitled Ventures, a seed and pre-seed stage VC investor that focuses on breakthrough technologies from Eastern Europe, is raising a new fund which will invest in early growth stage tech companies in the CEE region. The firm has offices in London, Moscow and Riga, acting as a venture capital
Pan-European asset manager Tikehau Capital’s subsidiary Ace Management has held a EUR630 million first close of Ace Aero Partenaires, a fund focused on helping companies in the aviation industry that have been severely affected by the Covid-19 pandemic. The initiative was first announced last June by Bruno Le Maire, Minister
Eurazeo has completed a EUR80 million investment from its China Acceleration Fund in DORC (Dutch Ophthalmic Research Center), a specialist in the area of vitreoretinal surgery.
Advent France Biotechnology and Invivo Ventures have invested EUR4.25 million into Valencia-based Arthex Biotech, a pre-clinical stage life sciences company focused on the development of next generation antisense RNA therapies. The latest round follows on from an initial seed round of EUR2.7 million by Invivo and CDTI-Innvierte in December 2019,
09 October, 2024 – 8:30 am
14 November, 2024 – 5:00 pm
09 October, 2024 – 5:00 pm
09 October, 2024 – 6:00 pm
